Subscribe or Manage Preferences

AVBCC 2015 5th Annual Conference

Washington, DC—The COME HOME initiative, a 7-member oncology medical home practice partnership, has documented significant reductions in hospitalization rates, inpatient days, and total cost of care of approximately $5 million over a 6-month period, said Barbara L. McAneny, MD, at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
Washington, DC-An evolving knowledge of cancer biology and the availability of comprehensive genetic testing engender a need for tools that help oncologists integrate these data and select therapy, said Gary Palmer, MD, Chief Medical Officer, NantHealth, Los Angeles, CA, in delivering his keynote address at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
To take full benefit of advances made possible by Next-Generation Sequencing, more American patients with cancer must be involved in clinical trials, said Raju Kucherlapati, PhD, Professor of Genetics, Harvard Medical School, at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
The Triple Aim of better patient care, lower spending by payers, and the maintenance of financially viable practices and hospitals is achievable with condition-based payment models in oncology, said Harold D. Miller, MS, President and Chief Executive Officer, Center for Healthcare Quality and Payment Reform, at the Fifth Annual Conference of the Association for Value-­Based Cancer Care.
Washington, DC—The role of oncology specialty pharmacy in helping to streamline medication delivery for patients with cancer was the subject of a panel discussion that took place at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
Washington, DC—The Community Oncology Alliance (COA) is in the midst of developing an oncology medical home program. Ten oncology practices have participated in COA’s pilot program, and the oncology medical home model will be expanding to 50 more practices during 2016.
The increasing number of specialty drugs will drive pharmaceutical spending and exert greater pressure on the demonstration of the value of these drugs, said Douglas Long, Vice President of Industry Relations at IMS Health, at the Fifth Annual Conference of the Association for Value-­Based Cancer Care.
Washington, DC—Emerging trends in oncology care management include economic transparency, high-value narrow networks (now also referred to as “power networks”), patient–provider profile matching, and an evolving role for risk management. Narrow networks have been shown to lower overall costs and premiums, reduce care variation, and increase patient outcomes and satisfaction, said Grant D. Lawless, RPh, MD, Associate Professor, Clinical Pharmacy and Economics, University of Southern California, Los Angeles, at the Fifth Annual Con­ference of the Association for Value-Based Cancer Care.
Washington, DC—Personalized medicine is the best way to take advantage of innovation in therapy, but the method in which it is paid for must be addressed to fully realize its potential, said Michael Kolodziej, MD, National Medical Director, Oncology Solutions, Aetna, at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
Experts at the AVBCC 5th Annual Conference suggested that retrospective analyses of big data should more effectively differentiate between different approaches to cancer care based on care quality and evidence-based, clinically meaningful outcomes. Data silos can help in the short-term to prioritize process measures.
Page 1 of 2
Results 1 - 10 of 16
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology